Yifei Mo

1.4k total citations · 1 hit paper
34 papers, 984 citations indexed

About

Yifei Mo is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Yifei Mo has authored 34 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Genetics and 6 papers in Surgery. Recurrent topics in Yifei Mo's work include Diabetes Management and Research (21 papers), Diabetes and associated disorders (12 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Yifei Mo is often cited by papers focused on Diabetes Management and Research (21 papers), Diabetes and associated disorders (12 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (10 papers). Yifei Mo collaborates with scholars based in China, United States and India. Yifei Mo's co-authors include Jian Zhou, Yuqian Bao, Xiaojing Ma, Weiping Jia, Jingyi Lu, Wei Lu, Wei Zhu, Robert A. Vigersky, Lingwen Ying and Lei Zhang and has published in prestigious journals such as PLoS ONE, Diabetes Care and Clinica Chimica Acta.

In The Last Decade

Yifei Mo

33 papers receiving 960 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes

2018 355 citations Jingyi Lu, Xiaojing Ma et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yifei Mo China	16	769	303	267	155	115	34	984
R. Rottiers Belgium	15	714 0.9×	467 1.5×	444 1.7×	142 0.9×	111 1.0×	38	1.2k
Ling Ge United States	11	483 0.6×	73 0.2×	110 0.4×	192 1.2×	190 1.7×	24	798
Philip A. Coates United Kingdom	11	324 0.4×	104 0.3×	173 0.6×	92 0.6×	93 0.8×	16	540
Stefanie Eising Denmark	12	274 0.4×	244 0.8×	143 0.5×	63 0.4×	35 0.3×	20	580
Elisabeth Björk Sweden	11	363 0.5×	336 1.1×	270 1.0×	63 0.4×	35 0.3×	12	640
K. Py�r�l� Finland	9	456 0.6×	84 0.3×	157 0.6×	115 0.7×	300 2.6×	13	774
М. А. Исаков Russia	10	305 0.4×	80 0.3×	84 0.3×	58 0.4×	97 0.8×	38	532
Anna V. Zheleznyakova Russia	9	289 0.4×	76 0.3×	77 0.3×	54 0.3×	100 0.9×	31	502
Gregory G. Passmore United States	14	202 0.3×	280 0.9×	81 0.3×	62 0.4×	84 0.7×	30	557
Jadwiga Peczyńska Poland	10	166 0.2×	128 0.4×	105 0.4×	46 0.3×	108 0.9×	42	424

Countries citing papers authored by Yifei Mo

Since Specialization

Citations

This map shows the geographic impact of Yifei Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifei Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifei Mo more than expected).

Fields of papers citing papers by Yifei Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifei Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifei Mo. The network helps show where Yifei Mo may publish in the future.

Co-authorship network of co-authors of Yifei Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Yifei Mo. A scholar is included among the top collaborators of Yifei Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifei Mo. Yifei Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Yun, et al.. (2024). Habitual use of glucosamine and adverse liver outcomes among patients with type 2 diabetes and MASLD. Liver International. 44(9). 2359–2367. 1 indexed citations

Lu, Jingyi, et al.. (2024). Potential modifying effect of grip strength on the association between glycated hemoglobin (HbA1c) and all-cause mortality in older adults with type 2 diabetes: Evidence from UK Biobank. Chinese Medical Journal. 137(12). 1501–1503. 1 indexed citations

Peng, Peng, Jingyi Lu, Yun Shen, et al.. (2024). Severe dawn phenomenon predicts long‐term risk of all‐cause mortality in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews. 40(4). e3813–e3813. 1 indexed citations

Mo, Yifei, Jingyi Lu, & Jian Zhou. (2023). Glycemic variability: Measurement, target, impact on complications of diabetes and does it really matter?. Journal of Diabetes Investigation. 15(1). 5–14. 19 indexed citations

Li, Cheng, et al.. (2021). Increased Serum GDF15 Related to Improvement in Metabolism by Lifestyle Intervention Among Young Overweight and Obese Adults. Diabetes Metabolic Syndrome and Obesity. Volume 14. 1195–1202. 15 indexed citations

Yin, Jun, Xiaojing Ma, Yifei Mo, et al.. (2021). Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial. Frontiers of Medicine. 15(3). 460–471. 18 indexed citations

Shen, Yun, Jingyi Lu, Xiaojing Ma, et al.. (2020). Association between 1,5-Anhydroglucitol and Acute C Peptide Response to Arginine among Patients with Type 2 Diabetes. Journal of Diabetes Research. 2020. 1–7. 8 indexed citations

Dai, Dongjun, Yifei Mo, & Jian Zhou. (2020). Glycated albumin and its variability: Clinical significance, research progress and overall review. Obesity Medicine. 19. 100256–100256. 1 indexed citations

Li, Cheng, Xiaojing Ma, Jun Yin, et al.. (2020). The dawn phenomenon across the glycemic continuum: Implications for defining dysglycemia. Diabetes Research and Clinical Practice. 166. 108308–108308. 10 indexed citations

10.

Lu, Jingyi, Xiaojing Ma, Lei Zhang, et al.. (2020). Glycemic variability modifies the relationship between time in range and hemoglobin A1c estimated from continuous glucose monitoring: A preliminary study. Diabetes Research and Clinical Practice. 161. 108032–108032. 37 indexed citations

11.

Lu, Jingyi, Xiaojing Ma, Yun Shen, et al.. (2019). Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes. Diabetes Technology & Therapeutics. 22(2). 72–78. 149 indexed citations

12.

Mo, Yifei, Jian Zhou, Xiaojing Ma, et al.. (2018). Haemoglobin A1c variability as an independent correlate of atherosclerosis and cardiovascular disease in Chinese type 2 diabetes. Diabetes and Vascular Disease Research. 15(5). 402–408. 21 indexed citations

13.

He, Xingxing, Yifei Mo, Xiaojing Ma, et al.. (2018). Associations of body mass index with glycated albumin and glycated albumin/glycated hemoglobin A 1c ratio in Chinese diabetic and non-diabetic populations. Clinica Chimica Acta. 484. 117–121. 21 indexed citations

14.

Lu, Jingyi, Xiaojing Ma, Jian Zhou, et al.. (2018). Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care. 41(11). 2370–2376. 355 indexed citations breakdown →

15.

Mo, Yifei, Xiaojing Ma, Hong Li, et al.. (2016). Relationship between glycated albumin and glycated hemoglobin according to glucose tolerance status: A multicenter study. Diabetes Research and Clinical Practice. 120. S73–S73. 1 indexed citations

16.

Lu, Jingyi, Haoyong Yu, Yifei Mo, et al.. (2015). Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes. PLoS ONE. 10(11). e0142207–e0142207. 7 indexed citations

17.

Zhou, Jian, Jingyi Lu, Hong Li, et al.. (2015). Differential Therapeutic Effects of Nateglinide and Acarbose on Fasting and Postprandial Lipid Profiles: A Randomized Trial. Diabetes Technology & Therapeutics. 17(4). 229–234. 3 indexed citations

18.

Zhou, Jian, Hong Li, Xiuzhen Zhang, et al.. (2013). Nateglinide and Acarbose Are Comparably Effective Reducers of Postprandial Glycemic Excursions in Chinese Antihyperglycemic Agent–Naive Subjects with Type 2 Diabetes. Diabetes Technology & Therapeutics. 15(6). 481–488. 13 indexed citations

19.

Zhou, Jian, Yifei Mo, Hong Li, et al.. (2013). Alanine Aminotransferase Is Associated with an Adverse Nocturnal Blood Glucose Profile in Individuals with Normal Glucose Regulation. PLoS ONE. 8(2). e56072–e56072. 5 indexed citations

20.

Zhou, Jian, Yuqian Bao, Xiaojing Ma, et al.. (2012). Accuracy assessment of continuous glucose monitoring by frequent venous blood collection in patients with type 2 diabetes mellitus. 4(9). 523–528.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact